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PENEROKAAN AKTINOBAKTERIA PENGHASIL ANTIBIOTIK 
DARIPADA ENAPAN BAKAU TERPILIH DI MALAYSIA 
 ABSTRAK 
Kemunculan pantas bakteria patogen rintang pelbagai drug telah menyeru 
penyelidikan intensif dalam meneroka metabolit antibakteria baru dan poten.  
Aktinobakteria merupakan salah satu penghasil utama metabolit sekunder 
antibakteria.  Antara sumber yang boleh dipercayai bagi pemencilan aktinobakteria 
adalah tanah hutan dan enapan marin.  Bakau adalah persekitaran marin yang kaya 
dengan biodiversiti, namun kurang diteroka bagi pemencilan aktinobakteria.  
Sewajarnya, kajian ini dijalankan dengan tujuan utama bagi memencil dan 
menyaring aktinobakteria penghasil antibiotik daripada enapan bakau.  Enapan bakau 
disampel daripada persekitaran bakau terletak di Balik Pulau, Pulau Pinang, 
Malaysia.  Sebanyak 131 pencilan aktinobakteria telah berjaya diperoleh 
menggunakan gabungan pra-rawatan selektif dan medium pencilan selektif.  
Saringan awal pencilan ini terhadap lima spesis bakteria Gram-positif dan Gram-
negatif menggunakan kaedah calit silang plat menunjukkan sebanyak 54 % pencilan 
mampu menghasilkan metabolit antibakteria.  Dalam kalangan pencilan aktif ini, 
70 % mempunyai ciri antibakteria spektrum luas yang mana ia mampu merencat 
pertumbuhan bakteria Gram-positif dan Gram-negatif, 24 % mempunyai ciri 
antibakteria spektrum sempit yang hanya merencat pertumbuhan bakteria Gram-
positif dan hanya 6 % merencat pertumbuhan bakteria Gram-negatif.  Sebanyak lima 
pencilan poten dengan ciri antibakteria spektrum luas dipilih bagi kultivasi dalam 
tiga liter fermentasi kultur tenggelam menggunakan bioreaktor turus buih.  Ekstrak 
mentah kaldu fermentasi diperoleh menggunakan pengestrakan pelarut dengan etil 
asetat pada nisbah 1:1 dan diuji bagi memperoleh nilai kepekatan perencat minima 
     xvii 
(MIC) dan kepekatan bakterisidal minima (MBC) terhadap 17 bakteria ujikaji.  Nilai 
MIC terendah diperoleh adalah 9.77 Pg/mL terhadap pencilan klinikal Pseudomonas 
aeruginosa, Enterococcus faecalis dan Listeria monocytogenes ATCC 19114.  Tiada 
nilai MBC direkodkan walaupun pada kepekatan tertinggi ekstrak etil asetat pada 
5000 Pg/mL.  Penulenan awal bagi ekstrak etil asetat aktinobakteria paling aktif 
menggunakan kromatografi turus menghasilkan sebanyak 11 pecahan.  Hanya 
Pecahan 1 hingga 4 menunjukkan aktiviti antibakteria terhadap pencilan klinikal 
P. aeruginosa, E. faecalis, Staphylococcus aureus, Staphylococcus aureus rintang 
metisilin, Shigella boydii ATCC 9207, dan Staphylococcus aureus ATCC 12600.  
Pecahan 1 mempamerkan MIC dan MBC terendah dengan nilai 0.15 Pg/mL and 
2500 Pg/mL masing-masing, terhadap P. aeruginosa dan E. faecalis.  Pecahan 1 
dipisahkan lagi menggunakan kromatografi lapisan nipis dan menghasilkan tiga 
tompok.  Bioautografi bagi tompok ini menggunakan S. aureus ATCC 12600 
menunjukkan hanya satu tompok aktif pada nilai Rf 0.88.  Analisa kromatografi 
cecair prestasi ultra mengesan hanya satu puncak utama dalam kromatogram yang 
mungkin merupakan metabolit yang penting.  Satu pencilan aktinobakteria dengan 
ekstrak etil asetat paling aktif, bernama pencilan PBD-310J dipilih bagi pencirian 
dan pengenalpastian aktinobakteria.  Pencirian melalui ciri morfologi dan fisiologi, 
dan pengenalpastian molekul 16S rRNA telah memadankan pencilan tersebut 
sebagai salah satu spesies Streptomyces dan berkait rapat dengan Streptomyces 
praecox.  Penemuan dalam kajian ini menunjukkan bahawa enapan bakau Malaysia 
mempunyai simpanan aktinobakteria penghasil antibakteria yang baik, yang 
mungkin boleh dijadikan calon agen antibakteria pada masa hadapan. 
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DISCOVERY OF ANTIBACTERIAL-PRODUCING ACTINOBACTERIA 
FROM SELECTED MALAYSIAN MANGROVE SEDIMENTS 
 ABSTRACT 
The rapid emergence of multi-drug resistant pathogenic bacteria has called for 
intensive research on the discovery of new and potent antibacterial metabolites.  
Actinobacteria is one of the major producers of antibacterial secondary metabolites.  
Among the most reliable sources for the isolation of actinobacteria are forest soil and 
marine sediments.  Mangrove is a rich marine environment, but it is seldom explored 
for actinobacterial isolation.  Accordingly, the present study was carried out with the 
main aim to isolate and screen for potential antibacterial-producing actinobacteria 
from mangrove sediments.  The mangrove sediments were sampled from the 
mangrove environment located at Balik Pulau, Pulau Pinang, Malaysia.  A total of 
131 actinobacterial isolates were successfully isolated by using a combination of 
selective pre-treatment and isolation media.  Preliminary screening of these isolates 
against five species of Gram-positive and Gram-negative bacteria using cross streak 
plate method showed that 54 % of the isolates were capable of producing 
antibacterial metabolites.  Among these active isolates, 70 % have broad-spectrum 
antibacterial activity against both Gram-positive and Gram-negative test bacteria, 
24 % have narrow-spectrum antibacterial activity against only Gram-positive 
bacteria and 6 % against only Gram-negative test bacteria.  Five actinobacterial 
isolates with potent broad-spectrum antibacterial activity were selected for 
cultivation in three litres submerged culture fermentation using a bubble-column 
bioreactor.  The crude fermentation broth extract was obtained through solvent 
extraction using ethyl acetate at 1:1 ratio and tested for minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC) against 17 test 
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bacteria.  The lowest MIC value detected was 9.77 Pg/mL against the clinical 
isolates Pseudomonas aeruginosa, Enterococcus faecalis and Listeria 
monocytogenes ATCC 19114.  No MBC value was recorded even at the highest test 
concentration of 5000 Pg/mL of the ethyl acetate extract.  Preliminary purification of 
the most active actinobacterial ethyl acetate extract through column chromatography 
produced a total of 11 fractions.  Only Fractions 1 to 4 showed antibacterial activity 
against clinical isolates P. aeruginosa, E. faecalis, Staphylococcus aureus, Methicilin 
resistant Staphylococcus aureus, Shigella boydii ATCC 9207, and 
Staphylococcus aureus ATCC 12600.  Fraction 1 exhibited the lowest MIC and 
MBC values of 0.15 Pg/mL and 2500 Pg/mL, respectively against P. aeruginosa and 
E. faecalis.  Fraction 1 was further separated using thin layer chromatography, which 
produced three spots.  Bioautography of these spots against S. aureus ATCC 12600 
showed that only one spot with Rf value of 0.88 was active.  Ultra-performance 
liquid chromatography analysis also detected only one major peak in the 
chromatogram, which might be the possible metabolite of interest.  One 
actinobacterial isolate with the most active ethyl acetate extract, namely isolate 
PBD-310J was selected for isolate characterization and identification.  
Characterization through morphological and physiological characteristics, and the 
16S rRNA gene sequence showed that the isolate was a species of Streptomyces and 
closely related to Streptomyces praecox.  Thus, the finding from this study revealed 
that the Malaysian mangrove sediments showed a good reservoir of antibacterial-
producing actinobacteria which could be candidates for future antibacterial agent. 
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1.1       General introduction 
Infectious disease is defined as the illness that is caused by pathogens 
(bacteria, fungi, parasites or virus) that results from the transmission of the pathogens 
from an infected person, animal, or environment (Barreto et al., 2006).  Following 
the discovery of antimicrobial drugs over the past six decades, the statistics of 
infectious disease cases had descended steadily and some microbial infectious 
diseases were eliminated while others became controllable (Trent, 2005; Berdy, 
2012).  However, the recent emergence and dissemination of multidrug-resistant 
pathogens had caused the loss in efficacy of the present standard antimicrobial drugs, 
which jeopardized the infectious disease treatment (Rossolini et al., 2014).  In 2016, 
the World Health Organization (WHO) had reported that the infectious diseases were 
among the top 10 causes of death globally involving lower respiratory infections, 
where it had caused three millions death worldwide (WHO, 2018).  Antibiotic-
resistant bacteria such as carbapenem-resistant Acinetobacter baumannii, 
Pseudomonas aeruginosa, and members of Enterobacteriaceae (e.g. Klebsiella 
pneumonia, Escherichia coli, Enterobacter sp., Serratia sp., Proteus sp., and 
Morganella sp.) have developed a new way to resist antimicrobial drugs and can pass 
along the resistant genetic materials to other bacteria (WHO, 2017).  Carbapenems 
are E-Lactam class antibiotics, possessed the broadest spectrum of activity and 
highest potency, which used as a last-line antibiotic agent for treating serious 
multidrug-resistant infections (Papp-Wallace et al., 2011).  This critical situation 
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prompted WHO to issue a warning about these antibiotic-resistant pathogens, which 
require an immediate action (WHO, 2017).  Therefore, discovering a new and potent 
antimicrobial agent is urgently needed to curb this problem and research in this field 
is a priority. 
Antimicrobial drugs have been discovered from many sources such as from 
natural products (plants, animals, and microorganisms), as well as through chemical 
synthesis (Katz & Baltz, 2016).  The chemically synthesized antimicrobial drugs 
such as sulfa drugs and organoarsenicals developed by Domagk and collaborators 
(1930s) were commercialized for clinical use many years before the commercial use 
of penicillin by Alexander Fleming in 1940s (Lesch, 2007; Wright et al., 2014).  
These synthetic antimicrobial drugs worked great in killing bacterial pathogens 
without affecting the host cells and their production was economical due to their 
simple structures (Wright et al., 2014).  However, the major limitations of these 
antimicrobial drugs such as serious side effects, narrow spectrum of activity and the 
rapid acquirement of resistance by some bacteria pathogens toward these drugs had 
compromised their public usage (Kaufmann, 2008; Wright et al., 2014).  On the 
other hand, antimicrobial drugs also have been developed through the combination of 
chemical synthesis and the existing antimicrobial drugs from natural products.  
Derivatives of these semisynthetic antimicrobial drugs could be created with 
improved safety profiles, greater chemical stability, and increased antimicrobial 
potencies compared to their original form (Lye, 1998; Wright et al., 2014).  
Nonetheless, the acquirement of resistance by pathogens remains detrimental to the 
semisynthetic antimicrobial drugs.  The expensive production cost and time-
consuming development diminished the interest by the pharmaceutical company to 
develop these drugs (Rai et al., 2013).  Alternatively, natural product remains as one 
     3 
of the largest producers of antimicrobial drugs and other therapeutics. The plant-
based natural products contained a wide variety of metabolites, which have 
antimicrobial activity, but were poorly utilized as antimicrobial drugs due to their 
lack of clinical trials and toxic to human (Liener, 1970; Cowan, 1999).  Berdy (2012) 
also reported that the drugs from higher organisms have less variability and 
specificity compared to microbial products.  Amongst those natural product 
producers, about 47 % of them were originated from microbial products (Berdy, 
2012). 
Actinobacteria are known as the major producer of bioactive metabolites 
from microbial sources.  From more than 22,000 of the known microbial bioactive 
metabolites, 70 % of them originated from actinobacteria (Subramani & Aalbersberg, 
2012).  The Streptomyces genus produced almost 80 % of the metabolites and almost 
50 – 55 % of known antimicrobial drugs were introduced from this genus (Berdy, 
2012; Subramani & Aalbersberg, 2012).  Actinobacteria can be found in a variety of 
natural and man-made environments.  Nature remains the greatest reservoir of these 
unique metabolites where it was only a tip of the iceberg of actinobacteria and its 
antibacterial metabolites have been identified (Baltz, 2008).  Finding actinobacteria 
from special niches could increase the chances of finding a novel, potent, or 
structurally unique antimicrobial metabolite.  Hence, in this study, the mangrove 
environment was selected to isolate the bioactive actinobacteria.  Despite being very 
sensitive to disturbance and is sparsely distributed, mangrove environment is rich in 
diversity and highly productive (Jennerjahn & Ittekkot, 2002; Thatoi et al., 2013).  
The extreme tides, extreme temperature fluctuations, high salinity, anaerobic soils, 
and variable sediment types could result in the discovery of unique and hardy 
actinobacteria and associated metabolites (Azman et al., 2015).  Although the 
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discovery of antibacterial-producing actinobacteria from mangrove sediment have 
increased (Ventola, 2015), studies conducted in Malaysia is limited. 
1.2       Aim and specific objectives of research 
The main aim of the present study was to isolate and screen for antimicrobial 
producing actinobacteria, focusing on antibacterial producers from mangrove 
sediments.  The specific objectives were: 
 
1. To isolate actinobacteria from mangrove sediments using different pre-
treatments and selective isolation media. 
2. To determine the antibacterial activity of the isolated actinobacteria using 
cross streak method and tetrazolium microdilution assay. 
3. To partially purify the antibacterial metabolite present in the active 
actinobacterial ethyl acetate extract. 
4. To characterize and identify the most active antibacterial-producing 
actinobacterial isolate. 
 
     5 





2.1       Antibacterial agents 
The discovery of penicillin by Sir Alexander Fleming in 1929 had shed new 
light on chemotherapy in combating infectious bacterial diseases (Fleming, 1929).  
The active agent named ‗penicillin‘ produced by the mould, identified as 
Penicillium notatum, was successfully used as a potent antibacterial agent during 
World War ,, (Demain & Sanchez, 2009).  This finding was a starting point for the 
discovery of drugs from microbial sources.  During the golden era of antibiotics 
(1940-1970), many new compounds and their derivatives were discovered through 
screening processes, such as actinomycin, streptomycin, and streptothricin from 
actinobacteria by Waksman and his colleagues (Barka et al., 2016).  The chemical 
substances were termed as ‗antibiotics‘ by the American microbiologist Selman 
Waksman and his colleagues to describe the metabolites having antagonistic effects 
towards the growth of other microorganisms (Sengupta et al., 2013).  
The term ‗antimicrobial‘ and ‗antibacterial‘ are used interchangeably in many 
articles as they share a similar concept.  However, the difference between them is 
their target organisms.  Antibacterial could be anything that can kill or suppress the 
growth of bacteria while antimicrobial has a broader range of activity, acting against, 
not only bacteria but also fungi, protozoa, and viruses (Ioan, 2015).  Antimicrobial is 
also used synonymously with the term ‗antibiotics‘ (Ioan, 2015).  About 60 % of the 
currently known bioactive microbial metabolites (about 14,000 compounds) exhibit 
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antimicrobial activity, which includes antibacterial, antifungal, and antiprotozoal.  
Despite the tremendous development and success of antibiotics, infectious diseases 
still remain as one of the major causes of fatality, especially among children and 
elderly adults (Proc pio et al., 2012).  Often, increasingly more potent and resilient 
antibiotics are needed to save lives. 
 
2.1.1    Groups of antibacterial compounds 
Antibacterial compounds can originate from various sources, such as natural 
products or even chemical synthesis.  Their average molecular weights is around a 
few hundred Daltons (Da) (Berdy, 2005; Ebejer et al., 2016).  Actinomycetales 
species and other rare actinobacteria are known to produce the most complex, yet 
most versatile structures of antibacterial metabolites.  The molecular weights of their 
antibacterial compounds typically range from 400 to 800 Da for Streptomyces sp. 
and almost double for rare actinobacteria (Berdy, 2005). 
Generally, the antibacterial compounds are classified according to their 
mechanisms of action.  Each group has its own and specific interaction, targeting 
essential cellular functions to inhibit the growth of the bacteria (Kohanski et al., 
2010).  This complex process begins with the interaction between the molecule and 
specific target, with the eventual structural changes, disrupting the molecular and 
intracellular system (Proc pio et al., 2012).  Table 2.1 describes the classes of 
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Table 2.1: Classification of antibacterial compounds based on their mechanisms 
of action. 
(Schroeder et al., 2002; Kohanski et al., 2010) 
 
 
2.1.2    Antibacterial resistant among pathogenic bacteria 
Presently, antibacterial resistance especially multidrug-resistant bacteria 
(MDR) has become the biggest threat to human health, food security, and also to 
global evolution as reported by the World Health Organization (WHO, 2016).  This 
life-threatening problem can cause a catastrophe if left unchecked at the early stage.  
Antibacterial resistance is defined as the resistance of a bacterial pathogen to 
antibacterial drugs or medicine to, which it was previously sensitive to (Walsh, 
2013).  This has rendered bacterial infection treatment with commercial antibacterial 
drugs non-effective and severely limits treatment options (Kaye et al., 2017).  In 
February 2017, WHO had come up with a list of priority pathogens that need a new 
and effective antibiotic treatment due to resistance problem (Table 2.2). 




Inhibition of DNA 
replication 
The DNA replication is interfered by 
trapping DNA gyrase (topoisomerase ,,,) 
and topoisomerase ,V (topo,V) at the 
cleavage stage of DNA and preventing 
strand re-joining. 
Quinolones 
Inhibition of RNA 
synthesis 
Binding to DNA-dependent RNA 
polymerase and preventing the elongation 
chain of RNA, thereby making the 
transcription process incomplete. 
Rifamycins 
Inhibition of cell wall 
synthesis 
Inhibit cell wall synthesis, which results in 
cell morphological changes, induction of 




Inhibition of protein 
synthesis 
Blocking 50S and 30S ribosome sub-units 
from performing translation of mRNA. Macrolides 
Mycolic acid synthesis 
inhibitor 
Inhibit mycolic acid biosynthesis in 
mycobacterium. Isoniazid 
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Table 2.2: The priority level of bacterial pathogens that have developed 
resistance towards currently available antibiotics. (WHO, 2017) 
 
Level of priority Bacteria pathogens Resistance 
Critical 
Acinetobacter baumannii carbapenem-resistant 
Pseudomonas aeruginosa carbapenem-resistant 
Enterobacteriaceae  
(e.g. Klebsiella pneumonia, 
Escherichia coli, Enterobacter 
sp., Serratia sp., Proteus sp., 
and Morganella sp.) 
carbapenem-resistant 
3rd generation cephalosporin 
resistant 
High 






Helicobacter pylori clarithromycin-resistant 
Campylobacter sp. fluoroquinolone-resistant 







Streptococcus pneumoniae penicillin-non-susceptible 
Haemophilus influenzae ampicillin-resistant 
Shigella sp. fluoroquinolone-resistant 
 
There are a few causes for their resistance among these deadly pathogens.  
Most of the resistance cases are acquired from the clinical environment (Walsh, 
2013).  The aging and invasive surgical procedures have increased the risk of 
contracting a severe infection (Walsh, 2013).  As reported by Ventola (2015), factors 
such as the overuse of antibiotics, inappropriate prescription by physicians, extensive 
use in the agricultural sector, and poor regulatory barriers, are among the major 
contributors to this problem.  In a non-clinical or environmental setting, resistance 
can be acquired through the sharing of antibacterial-resistant plasmid from the 
resistant bacteria, especially from soil.  Studies by Oliver et al. (2001), Nordmann 
and Poirel (2005), and Zheng et al. (2011) have identified a few environmental 
bacteria such as Kluyvera sp., Shewanella sp., and Erythrobacterlitoratis sp. carrying 
antimicrobial resistance gene blaCTX-M, qnrA, and blaNDM, respectively.  However, 
the origin of plasmid-mediated resistance gene are still unknown (Walsh, 2013).  In 
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the natural relevance standpoint, it can be hypothesized that this might happen as a 
part of the ecological change and evolution of the bacteria (Walsh, 2013). 
To address this crisis, several approaches have been proposed by researchers.  
They include high-throughput screening, selection, enrichment process of new 
antimicrobial metabolites from non-traditional or less traditional sources, mining the 
microbial genomes to explore the gene specific for antimicrobial biosynthesis, 
studying of the microbial DNA from the environment by using metagenomics 
analysis, and transforming the old and forgotten natural compounds for new 
metabolic pathways (Baltz, 2008).  Malaysia is a country harbouring a great 
biodiversity in its ecosystem.  Thus, finding a potent antibacterial producer from the 
local environment can be possible with the aid of selective isolation and screening. 
 
2.1.3    Sources of antibacterial metabolites 
Antibiotics and any other natural products can be found in many kinds of 
organisms including prokaryotes and eukaryotes (Berdy, 2005).  They are the 
products of secondary metabolism, which might not appear beneficial for the host 
endurance under laboratory conditions, but might be the key of their survival in their 
native environment (Katz & Baltz, 2016).  Over the past 75 years, the majority of 
natural products, especially antimicrobial metabolites, have been extracted from 
bacteria, mainly by the Actinomycetaceae family (Berdy, 2012).  Among ~28,500 
antimicrobial metabolites from microbial sources, almost half of them were 
originated from actinobacteria (Table 2.3).  Besides microorganisms, higher plants 
and animals also contribute to the number.  In higher plant, active compounds such 
as alkaloids, flavonoids, phenolic derivates, as well as other natural products were 
found to exhibit antimicrobial activity (Sánchez & Demain, 2015).  Even though the 
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estimated number of compounds could reach up to the thousands, only few hundreds 
are being used in clinical practices (Spížek et al., 2016).  As many as 877 drugs have 
been commercialized between 1988 to 2008 and  almost 60 % of them were derived 
from natural sources (Lefevre et al., 2008).  Synthetic compounds or chemically-
synthesized antibiotics also contributed to the number of drugs available.  However, 
only 0.001 % of them were developed into consumable drugs compared to 0.2 – 0.3 
% of the microbial metabolites (Spížek et al., 2010). 
 
Table 2.3: Estimated number of antibiotic producers from microorganisms and 
higher organisms. 
Adapted from Berdy (2015) 
 
 
The actual number of microorganisms may be much higher than reported (Spížek et al., 
2016) 
 
Antibiotic producers Number of antibiotics produced 
Microorganisms  
    Eubacteriales            3500 
    Cyanobacteria            400 
    Myxobacteria            450 
    Actinobacteria            14,500 
       Streptomyces sp.            11,000 
       Other Actinobacteria            3400 
    Other bacteria including proteobacteria            800 
    Fungi            10,500 
       Microscopic fungi  
       (Penicillium, Aspergillus) 
           9000 
       Basidiomycetes            2900 
       Other fungi  
      (including slime moulds, yeast, etc) 
           110 
Total microorganisms            ~28,500 
Higher organisms  
   Terrestrial animals             1000-5000 
   Marine products (animals and plants)            6000-8000 
   Higher plants            15,000-16,000 
   Lower plants (mosses, lichens, and algae)            1500-2000 
Total            ~23,500-31,000 
Total estimated number of natural antibiotics            ~59,000 
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2.2       The actinobacteria 
 The phylum Actinobacteria is famously known primarily for their complex 
morphological criteria with the ability to form branching hyphae at some stages of 
their growth (Goodfellow & Williams, 1983).  This phylum is recognized as the 
largest taxonomic unit among the major lineages within the domain of Bacteria 
(Whitman et al., 2012).  Their genomic DNA comprises a high guanine (G) and 
cytosine (C) content, ranging from 51 % in some Corynebacteria to more than 70 % 
in some Streptomyces species (Ventura et al., 2007).  With their filamentous growth 
ability and distinct pellet formation in liquid cultures, actinobacteria were once 
referred to as ray fungi (―Strahlenpilze‖) or mould bacteria and were mistakenly 
classified as a group of fungi in the past (Benson & Schultz, 1990; Stackebrandt & 
Schumann, 2006; Margulis & Chapman, 2009).  However, following the discovery 
of streptomycin from Streptomyces griseus, the rapid increase in research focusing 
on this bacteria provided more evidence to later classify them as Gram-positive 
filamentous bacteria (Kokare, 2008).  It is believed that their ‗fungal‘ features 
evolved from the daughter cells that did not separate after binary fission, thereby 
forming a mass of visible filaments called mycelium (Margulis & Chapman, 2009). 
Actinobacteria are one of the successful, wide spread group of bacteria that 
can be found in a diversity of natural and man-made environment.  Most of them are 
strict saprophytes while others can form a parasitic and mutualistic associations with 
lower and higher plants and animals (Barka et al., 2016).  The presence of various 
types and numbers of actinobacteria in soil are totally influenced by the geographical 
conditions.  Normally, in comparison to the population of soil microbes, the 
actinobacterial population are relatively low and contains a predominance of 
Streptomyces species, which is tolerant to low pH environment (Davies & Williams, 
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1970).  However, rare genera of actinobacteria can be found in alkaline pH arid soils 
but may contain few Streptomycetes populations.  Alkaliphilic actinobacteria are a 
valuable source for new products of industrial interest, including enzymes and 
antimicrobial agents (Mitsuiki et al., 2004). 
 
2.2.1    Taxonomy and classification of actinobacteria 
Traditionally, the identification of bacteria was very laborious and time-
consuming, except for some pathogenic species (Muramatsu, 2008).  However, the 
advancement in the molecular identification systems, such as the rapid genome 
sequencing, has successfully transformed the landscape of taxonomic branching of 
microorganisms, especially the actinobacteria.  As a consequence, the phylogenetic 
relationships of actinobacteria have to be reconstructed on the basis of 16S rRNA 
gene sequence analysis to meet the requirement of the latest technology (Zhi et al., 
2009).  In recent classification by Whitman et al. (2012), this phylum has undergone 
some modifications by eliminating the subclass and suborder levels, and has been 
elevated to the rank of class and order, respectively, as shown in Figure 2.1 (Gao & 
Gupta, 2012).  Hence, this phylum now consists of six classes and 22 orders with a 
majority of orders belonging to the class Actinobacteria (Gao & Gupta, 2012). 
The conventional approaches for classification of actinobacteria involve their 
morphological, physiological and biochemical characteristics.  Early taxonomic 
works took advantage of the unique morphological characteristics and true branching 
of actinobacteria for their classification (Haley, 1954).  The International 
Streptomyces Project (ISP) by Shirling and Gottlieb (1966) is one of the 
identification and classification system based on the morphological appearance and 
pigmentation.  Through this system, the growth performance, aerial mass colour, the 
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presence of the reverse side pigment, and melanin formation of isolates were studied 
and compared (Radhakrishnan et al., 2013).  These cultural characteristics can also 
be used for recognizing an individual strain (Kumar et al., 2005). 
 
 
Figure 2.1: Proposed taxonomic branching for actinobacteria in the Bergey‘s Manual 
of Systematic Bacteriology. 
Adapted from Gao and Gupta (2012) 
 
Streptomyces is a famous genus from the order of Streptomycetales as it is 
the richest known source of antibacterial metabolites.  This genus received particular 
attention due to their abundance and important soil bacteria for recycling an organic 
matter, exhibits wide phylogenetic spread, and their important bioactive metabolites 
producers (Barka et al., 2016).  Streptomyces are chemoorganotrophic, filamentous 
bacteria, non-motile and non-acid-fast stain (Ikeda et al., 2003).  The colonies are 
slow growing and have a relatively smooth surface at the beginning, but later they 
develop into a thick and weft aerial mycelium that appear powdery, velvety, floccose 
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or granular (Ambarwati et al., 2012).  Spore chain morphology is critical in 
identifying certain actinobacteria for their respective taxonomic classes.  In 
Streptomyces, the spores are formed by the fragmentation of the hyphae growing out 
from the aerial mycelium, borne in a structure of straight to flexuous (rectus-
flexibilis), verticillate, open or closed spirals (spira), and open loops (relinaculam-
apertum) as shown Figure 2.2 (Pridham et al., 1958; Chater, 1993; Barka et al., 
2016).   
 
 
Figure 2.2: Structure of spore-bearing hyphae formed by Streptomyces.   
Adapted from Madigan and Brock (2011) and Anandan et al. (2016). 
 
In terms of spore chain length and number, Streptomyces are able to produce 
very long spore chains containing up to 100 spores (Pridham et al., 1958).  On the 
other hand, they also produce a volatile metabolite called geosmin, which 
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responsible for the earthy or soil-like smell (Jüttner & Watson, 2007).  Streptomyces 
also produce wide variety of pigments, which responsible for the colour of vegetative 
and aerial mycelia (Flardh & Buttner, 2009).  Biochemical tests also contributed a 
significant part in identification and characterization of Streptomyces.  They are 
catalase positive, able to degrade casein, gelatine, starch, and L-tyrosine (Smaoui et 
al., 2011). 
 
2.2.2    Actinobacteria as antibacterial producers 
 Actinobacteria are gaining attention as the gold mine of bioactive natural 
product producers as they have the ability to produce antifungals, antivirals, anti-
hypertensives, antitumor, immunosuppressive agents, and mainly antibiotics 
(Proc pio et al., 2012).  Even though the advancement in the field of chemical 
synthesis and engineered biosynthesis has greatly improved the production of 
synthetic drugs, nature remains the richest source for isolation of unique and 
versatile antibacterial compounds, which can be utilized directly or indirectly as 
reference compounds (Baltz, 2006; Pelaez, 2006).  Until now, actinobacteria remain 
as the major producers of antibiotics from the bacteria kingdom, making them very 
crucial and useful in antibiotic discovery (Berdy, 2005). 
 The first antibiotic from actinobacteria was discovered back in 1940 with the 
discovery of actinomycin A and B produced by Streptomyces antibioticus.  This was 
followed by streptothricin antibiotics from Streptomyces lavendulae (Waksman & 
Woodruff, 1940, 1942).  In a span of almost eight decades of actinobacterial 
discovery, Streptomyces have contributed almost 80 % of all antibiotics from 
actinobacteria origin (Iliĉ et al., 2007).  Table 2.4 presents a few antimicrobial 
metabolites produced by actinobacteria. 
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Table 2.4: Selected antibacterial producers among actinobacteria genera and 
their bioactive agents. 
 Adapted from Barka et al. (2016) 
 
 
2.3       Extreme environment as a source of actinobacterial isolation 
Actinobacteria were traditionally isolated from terrestrial sources and marine 
sediments.  For example, Streptomyces, Micromonospora, Rhodococcus, and 
Salinispora species can be found from soil and aquatic environment.  They also can 
be found as plant symbionts (e.g. Frankia sp.), animal or plant pathogens (e.g. 
Mycobacterium, Corynebacterium, and Nocardia species), and gastrointestinal 
commensals (e.g. Bifodobacterium sp.) (Barka et al., 2016).  The first report in the 
isolation of mycelium-forming actinobacteria was published by Weyland (1969) 
from marine sediment several decades ago (Baskaran et al., 2011). 
In recent studies, many researchers have focused their research to isolate 
actinobacteria from non-traditional sources.  The extreme environment, such as deep-
sea hydrothermal vents, hot springs, high salinity water reservoirs, and deserts, were 
explored for actinobacterial isolation (Kokare et al., 2004; Spížek et al., 2010; Ballav 
et al., 2015; Tiwari et al., 2015; Al-Dhabi et al., 2016).  These unusual and extreme 
Orders Species Bioactive agent Reference 
Micromonosporales Micromonospora purpurea Gentamicin Weinstein et al. (1963) 
Verrucosispora sp. Abyssomycin Bister et al. (2004) 
Actinomycetales Marinispora sp. Marinomycin Kwon et al. (2006) 
Corynebacteriales Nocardia lurida Ristocetin Williams et al. (1980) 
Pseudonocardiales Amycolatopsis orientalis Vancomycin Brigham and Pittenger (1956) 
Streptomycetales Streptomyces venezuelae  Chloramphenicol Shapiro and Vining (1983) 
Streptomyces griseus  Cycloheximide Kominek (1975) 
Streptomyces kanamyceticus  Kanamycin Umezawa et al. (1957) 
Streptomyces niveus  Novobiocin Kominek (1972) 
Streptomyces lavendulae  Streptothricin Waksman and Woodruff (1942) 
Streptomyces aureofaciens  Tetracycline Darken et al. (1960) 
Streptomyces mediterranei  Rifamycin Margalith and Beretta (1960) 
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environment may have an impact on the adaption mechanism of microorganisms, 
resulting in the production of unusual compounds (Meklat et al., 2011).  For 
example, the discovery of angucycline antibiotic with its nine derivatives including 
three new compounds by Hu et al. (2016) from a deep-sea marine sediment isolated 
Streptomyces with antimicrobial and antitumor properties. 
 
2.3.1    Ecology of actinobacteria 
 Most of the actinobacteria, especially the Streptomyces, are saprophytic in 
nature.  They are soil-dwelling microorganisms that have the most number of 
morphological changes compared to other bacteria and spend a majority of their life 
cycles as semi-dormant spores, especially under nutrient-limited condition (Mayfield 
et al., 1972).  They can be found in wide range of ecological environments, such as 
in soils and rocks (Arasu et al., 2009; Saravana et al., 2014), marine and freshwater 
(Gebreyohannes et al., 2013; Govindarajan et al., 2014), and even in desert and 
Antarctic soils (Balagurunathan et al., 2011; Marta et al., 2014). 
 Actinobacteria are commonly abundant in alkaline soils and soils with rich 
organic matter compared to in other habitats.  They can be found not only on the soil 
surface but also below the ground down to two metres in depth.  However, their 
population density can be influenced by the ecological habitat and climate condition, 
with typical population densities ranging from 106 to 109 per gram of soil 
(Goodfellow & Williams, 1983; Williams & Vickers, 1988).   Most actinobacteria 
are mesophilic, having optimal growing temperatures in the range of 25 to 30 qC.  
However, other factors such as soil moisture, pH, and salinity also influence their 
growth (Edwards, 1993).  Actinobacteria grow best at neutral pH but they can adapt 
well in the pH range of 6 to 9 (Kim et al., 2003). 
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 Actinobacteria have been found to have interactions with other organisms.  
They have developed a symbiosis interaction with others.  For example, the 
interaction with invertebrates such as termites, ants, gall midges and beetles, benefits 
the host or food source while at the same time, helps the mobility of microorganisms, 
as well as providing food and shelters (Seipke et al., 2012).  However, the interaction 
may not necessarily be only as symbionts as they can be in the form of antagonism, 
commensalism or even mutualism, and from facultative to obligate (Leung & Poulin, 
2008). 
In addition to invertebrates, actinobacteria have been observed to interact 
with vertebrates, namely as gut microbiota.  They can be found in various locations 
in the gastrointestinal tract, such as throat, distal oesophagus, gastric fluid, stomach 
mucosa, as well as in faeces (Barka et al., 2016).  They also play distinct roles as a 
plant-associated microbial community.  Since they are abundantly present in the soil, 
it is not surprising that actinobacteria have a crucial interaction with plants in the 
recycling of nutrient, symbionts, endophytes and even as pathogens (Bulgarelli et al., 
2013; Barka et al., 2016).  Many endophytic actinobacteria have been isolated from 
various plants for their metabolites.  Besides protecting the plants from infections, 
endophytes can improve the growth of their hosts by producing hormones (auxins) 
that can promote root growth and development (Coombs et al., 2004; Overvoorde et 
al., 2010).   
 On the contrary, some actinobacteria also causes a serious human and animal 
infections.  Mycobacterium tuberculosis is the most pathogenic actinobacteria, which 
caused a deadly infectious disease called tuberculosis or TB (Smith, 2003).  The 
genus Nocardia (e.g. Nocardia asteroides) is one of the aerobic actinobacteria 
genera, which causes a wide spectrum of clinical diseases in human and also 
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animals, such as dogs, cattle, horses, and swine (McNeil & Brown, 1994).  Other 
pathogenic aerobic actinobacteria is Rhodococcus sp., which can cause infection in 
immunocompromised individuals.  Primary pulmonary Rhodococcus equi infection 
(pneumonia and lung abscesses) is one of the frequently reported bacterial infections 
caused by Rhodococcus sp. (McNeil & Brown, 1994).  On the other hand, 
Streptomyces sp. rarely caused an infection in human.  Human infections, such as 
mycetoma (chronic skin and subcutaneous tissue infection) linked to this genus are 
rare (Kapadia et al., 2007).  Most of the invasive infection caused by Streptomyces 
sp. are commonly associated with bacteraemia and lung infection, such as 
pneumonitis, abscess, and pneumonia (Dunne et al., 1998).  
 
2.3.2    Actinobacteria from mangrove environment 
Mangrove is a vegetated ecosystem comprising of unique plants species 
(ferns, shrubs, palms, and trees) found in the intertidal zone of coastal and estuarine 
environments above the mean sea level (Duke, 2013).  Mangroves occupy almost 
150,000 km2 globally, spread across tropical and subtropical coastlines, and highly 
rich in diversity with at least 73 mangrove species and hybrids recorded (Holguin et 
al., 2001; Krauss & Friess, 2011).  In Malaysia, only 1.4 % (4691 km2) of its land is 
covered with mangrove (Hamilton & Casey, 2016).  Peninsular Malaysia constitute 
17 % of the total mangrove area while majority are found in Eastern Malaysia in 
Sabah (58.6 %) and Sarawak (24.4 %) (Kanniah et al., 2015).  The majority of 
mangroves are river-dominated type found on large deltaic plains while  the rest are 
tide-dominated, drowned valley settings, and also carbonate settings (Chong, 2006).  
Malaysia is also the home among the most diverse mangrove ecosystem in the world, 
namely the Merbok Estuary (Spalding, 2010).  Despite being diverse and 
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socioeconomically important (Chong, 2006), mangroves are under constant threat 
from human activities (Heumann, 2011).  It was estimated about one-third of the 
mangrove forest was converted into urban areas, aquaculture, and deforestation 
within the past 50 years (Holguin et al., 2001; Heumann, 2011; Sahriman et al., 
2017).  In Malaysia, about 30 % of mangrove loss was recorded in 1990 and this 
trend is expected to continue with 1 % mangrove loss annually (Gong & Ong, 1990; 
Sahriman et al., 2017). 
The mangrove ecosystem is inhabited by resident and associated mangrove 
species demonstrating tolerance to extreme changes in their environment (Kathiresan 
& Bingham, 2001; Tomlinson, 2016).  The sediment or substrate consists of sand and 
mud (mixture of silt and clay), and rich in organic matter (Hossain & Nuruddin, 
2016).  A strong hydrogen sulphide (H2S) smell also can be found in muddy 
sediment, indicating the completely anaerobic property of water logged-soil 
(Nickerson & Thibodeau, 1985; Tomlinson, 2016). 
Microorganisms are important biotic components in influencing the 
productivity of mangroves (Holguin et al., 2001).  They help in the decomposition of 
organic matter, mineralization of organic compound, and also supply nutrients to 
plants (McGuire et al., 2012).  Metagenomic study of the microbial population by 
Basak et al. (2015) in Sundarbans mangrove, India, showed that Actinobacteria was 
one of the dominant phyla along with Proteobacteria, Chloroflexi, Firmicutes, 
Bacteroidetes, Acidobacteria, and Nitrospirae.  A study by Andreote et al. (2012) and 
Thompson et al. (2013) on microbial populations in mangrove area along San Paulo 
coast, Rio de Janeiro, and Bahia, showed that the percentage of actinobacteria were 
5.4 - 12.2 %, 8.4 %, and 7.5 %, respectively.  Recent studies by Ruan et al. (2015), 
Ser et al. (2015), and Zainal et al. (2016)  also showed that the mangrove 
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environment was a promising source for isolation of novel species of actinobacteria, 
as these authors have successfully isolated novel Streptomyces ferrugineus, 
Streptomyces gilvigriseus, and Streptomyces humi from mangrove sediments. 
 
2.3.3    Previous discoveries of antibacterial-producing actinobacteria from 
mangrove sediments 
Recently, the mangrove ecosystem has become popular for the discovery of 
novel bioactive metabolites (Azman et al., 2015).  The discovery of a uniquely 
structured compound from this ecosystem lead directly to the development of novel 
antibacterial agents that are effective against multidrug resistant pathogens (Lam, 
2006).  In 2014, almost 73 novel compounds proven as a potential new antibiotics, 
antiviral, antitumor, and antioxidant have been isolated from mangrove 
Actinobacteria (Xu et al., 2014).  For instance, the discovery of new Azalomycin F 
analogs from mangrove Streptomyces species showed a potent antimicrobial activity 
and anticancer activity (MIC 1.56 – 25.0 Pg/mL) (Yuan et al., 2013).  Isolation of 
Streptomyces olivaceus (MSU3) from rhizosphere soil of mangrove plant, 
Rhizophora mucronata also showed a potent antibacterial activity against bacterial 
pathogens (MIC 0.625 Pg/mL against Streptococcus sp.) (Sanjivkumar et al., 2016).   
However, studies on isolation of actinobacteria from Malaysian mangrove for 
their antibacterial activity are still scarce.  There were few studies reported for the 
isolation of actinobacteria from Malaysian mangrove sediments and their 
antimicrobial activity by Lee et al. (2014), Zainal Abidin et al. (2016), Ariffin et al. 
(2017), and Azman et al. (2017).  Study by Lee et al. (2014) was the first report for 
isolation of actinobacteria from mangrove sediments from the east coast of Malaysia.  
Nevertheless, most of the antimicrobial assays conducted in their studies were mostly 
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preliminary study without the quantitative determination of minimum inhibitory 
concentration (MIC) and minimum bactericidal concentration (MBC). 
 
2.4       Antimicrobial assay 
 There are many in vitro antimicrobial susceptibility assays that have been 
introduced for the detection and evaluation of antimicrobial activity, both 
qualitatively and quantitatively.  Even though these methods share the same final 
goals, the principles behind them are not necessarily the same.  The final results are 
often influenced by the method, the microorganisms used, and the solubility of the 
compound tested (Tripoli et al., 2007; Valgas et al., 2007).  Ideally, the assays 
should be simple to conduct, inexpensive, reproducible, rapid, and maximize sample 
throughput (Hostettmann et al., 1997).   
 Standard methods have been proposed by various parties in order to 
standardize the methodology for antimicrobial assays.  For example, methods for 
dilution in the antimicrobial susceptibility test by Clinical and Laboratory Standards 
Institute (CLSI), and antimicrobial susceptibility testing, European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) disk diffusion method by the 
European Society of Clinical Microbiology and Infectious Diseases, have been 
introduced for global reference (Cockerill et al., 2012; EUCAST, 2015).  
Modifications and improvements of the methodology have also been made to 
enhance their reliability (Balouiri et al., 2016).  For example, the use of tetrazolium 
salts as an indicator of bacteria growth in the colorimetric method helps in faster and 
safer bioassay test, giving more reliable results (Eloff, 1998; Grare et al., 2008). 
 The agar disk-diffusion method is the earliest antimicrobial susceptibility test 
developed by Heatley (1944).  This method is still widely used in many clinical 
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microbiology laboratories for routine antimicrobial susceptibility assay (Balouiri et 
al., 2016).  In addition to the agar disk-diffusion, other diffusion methods, such as 
the agar plug diffusion method, the agar well diffusion method, the cross streak 
method and the antimicrobial gradient method (E-test) are other available 
susceptibility tests (Hausdorfer et al., 1998; Magaldi et al., 2004; 
Lertcanawanichakul & Sawangnop, 2008; Elleuch et al., 2010).  The agar plug 
diffusion is frequently used to emphasize the antagonism activity between 
microorganism while the E-test is a combination of the dilution and the diffusion 
method for the determination of minimum inhibitory concentration value (MIC).  On 
the other hand, the cross streak method is the most suitable method for rapid 
screening of antimicrobial producers and antagonism bioassay (Lertcanawanichakul 
& Sawangnop, 2008). 
 The dilution method is considered as the only standard and reliable in vitro 
method for MIC determination to obtain a quantitative value of the antagonistic 
activity.  This method provides a way to estimate the concentration of the 
antimicrobial agent needed against the tested pathogens (Balouiri et al., 2016).  The 
most common dilution method used is the broth macro- or microdilution method and 
the agar dilution method (Cockerill et al., 2012).  The antimicrobial assay coupled 
with thin layer chromatography (TLC) is also becoming a great tool for the 
separation and the detection of antimicrobial compounds.  This method was 
pioneered by Goodall and Levi (1947) using a combination of paper chromatography 
and contact bioautography to detect different penicillin compounds.  Later, this 
method was improved by Fischer and Lautner (1961) using thin layer 
chromatography (TLC).  As this method combines both biological and chemical 
detection methods, it is widely used for screening of organic extracts for 
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antimicrobial and antifungal activity (Mehrabani et al., 2013; Messaoudi et al., 
2015). 
 
2.5       Actinobacterial fermentation 
In term of metabolite production strategies, many researchers are still 
restricted to the shake flask level in the laboratory scale.  This method is quite 
laborious, offering a limited prospect of parameter controls (Marwick et al., 1999).  
It is also unsuitable when cultivating organisms with low product yields.  Unlike any 
other unicellular microorganisms, filamentous microorganisms tend to prefer the 
growth on solid media compared to liquid media due to their growth physiology 
(Prosser & Tough, 1991; Minas et al., 2000).  However, most metabolite production 
still takes place in submerged cultures, especially the production of antibiotics from 
Streptomyces (Fernandez & Sanchez, 2001). 
Actinobacterial morphology can vary depending on the cultivation medium 
(Dobson et al., 2008).  On solid media, colonization takes place by the formation of 
apical and branched growth whereas in liquid media, they tend to grow in the form of 
dispersed mycelia, pellets or clumps (entangled filaments)  (Minas et al., 2000; 
Pamboukian et al., 2002).  This physiology may vary depending on the species, size 
of spore inoculum and also the cultivation condition in the liquid culture (Dobson et 
al., 2008).  The stirred tank bioreactor and the bubble column bioreactor are two 
commonly utilized bioreactors in a variety of bioprocesses (Felix & Gomez, 2009).  
These types of bioreactors have a very different system, mechanical setup and favour 
a different physiology of microorganisms.  Cultivation of actinobacteria in 
submerged culture fermentation is not an easy process since their unique morphology 
may influence the fermentation broth rheological properties and cause problems in 
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mass transfer and mixing (Olsvik et al., 1993; Pamboukian et al., 2002).  The bubble 
column and airlift bioreactor systems are more suitable fermentation systems to 
cultivate filamentous bacteria due to the low-shear environment they provide 
compared to that of the stirred tank bioreactor (Felix & Gomez, 2009). 
When running a fermentation, it is important to consider the whole 
bioprocess system.  Downstream processing is one of the crucial parts in 
bioprocessing, contributing significantly to the total cost of production.  Hence, the 
bioreactor needs to be set up to complement an easy integration of downstream 
product separation and purification strategies (Marwick et al., 1999).  A few 
approaches have been used by researchers for an easy downstream process, such as 
the use of the biopolymer matrix polycaprolactone/polyethylene glycol based 
membrane (PCL/PEG) for cell growth support and separation, and ceramic 
microfiltration membrane for cell recycle  (Lu et al., 2012; Scaffaro et al., 2016).  In 
this study, a fabric mesh is used as a matrix for cell attachment and biomass 
separation for convenience and availability. 
